| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |